PMDI
PSYCHEMEDICS CORP
Key Financials
Operating Income
$-1893000
↑ 35.2%
Revenue
$39.7M
↑ 1.8%
Net Income
$-1861000
↑ 55.2%
Gross Profit
$7.1M
↓ 15.6%
EPS (Diluted)
$-0.19
↓ 58.3%
Total Assets
$8.3M
↓ 32.5%
Total Liabilities
$3.2M
↓ 43.6%
Shareholders' Equity
$5.1M
↓ 23.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/24/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| S-8 POS | 3/19/2025 | View on SEC |
| 15-12G | 1/2/2025 | View on SEC |
| 4 | 12/17/2024 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PMDI |
| Company Name | PSYCHEMEDICS CORP |
| CIK | 806517 |
| Sector | Services-Medical Laboratories |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 8071 |
| SIC Description | Services-Medical Laboratories |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 978-206-8220 |